Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2775 results

Statement / Apr 24, 2026

Novartis withdraws EMA application for adding new indication for Pluvicto®
Press release / Apr 24, 2026

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)

If approved, Itvisma (intrathecal onasemnogene abeparvovec) will be first and only gene replacement therapy for children two years and older, teens and adults with SMA in the European UnionItvisma…
Clinical Trials / Apr 21, 2026

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
Clinical Trials / Apr 16, 2026

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical Trials / Apr 16, 2026

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Clinical Trials / Apr 15, 2026

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Clinical Trials / Apr 14, 2026

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction
Clinical Trials / Apr 14, 2026

A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy
Clinical Trials / Apr 08, 2026

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Clinical Trials / Apr 02, 2026

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China